LASTACAFT is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Rebel Distributors Corp. The primary component is Alcaftadine.
Product ID | 42254-288_4b8c6afe-2d76-46c7-a23e-99db5e180ff6 |
NDC | 42254-288 |
Product Type | Human Prescription Drug |
Proprietary Name | LASTACAFT |
Generic Name | Alcaftadine |
Dosage Form | Solution/ Drops |
Route of Administration | OPHTHALMIC |
Marketing Start Date | 2010-11-01 |
Marketing Category | NDA / NDA |
Application Number | NDA022134 |
Labeler Name | Rebel Distributors Corp |
Substance Name | ALCAFTADINE |
Active Ingredient Strength | 3 mg/mL |
Pharm Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 2010-11-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022134 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2010-11-01 |
Inactivation Date | 2019-09-24 |
Ingredient | Strength |
---|---|
ALCAFTADINE | 2.5 mg/mL |
SPL SET ID: | 4b8c6afe-2d76-46c7-a23e-99db5e180ff6 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0023-4290 | LASTACAFT | alcaftadine |
0023-4291 | LASTACAFT | alcaftadine |
42254-288 | LASTACAFT | alcaftadine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LASTACAFT 85168259 4071760 Live/Registered |
Allergan, Inc. 2010-11-03 |
LASTACAFT 85088422 4003795 Live/Registered |
Allergan, Inc. 2010-07-20 |